Satya Nadella has unveiled BioEmu, Microsoft's new AI initiative aimed at accelerating drug discovery processes.

OpenAI’s contract clause could cut off Microsoft’s access to new AI models if AGI is declared, forcing high-stakes renegotiation of their partnership.

Understanding protein motion is essential to understanding biology and advancing drug discovery,” said Nadella, in a post on ...

Microsoft's CEO, Satya Nadella, has announced BioEmu-1, a new AI system designed to accelerate drug discovery by decoding ...

Microsoft’s new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya ...

Microsoft's new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya Nade ...

Microsoft's BioEmu, an AI-driven model, decodes protein motion to enhance drug discovery, offering rapid insights into ...

Microsoft’s new AI system BioEmu will help decode protein motion and help in faster discovery of drugs, said CEO Satya ...

Indian immigrants are the leading group of foreign-born billionaires in the United States, according to the latest Forbes ...

Indian immigrants are making their mark on billionaires lists. India is currently the leading country of origin for ...

Google wants its AI models to become bigger in coding. It has now hired the CEO of one of the top startups in that area.

The implications for enterprise AI are significant. Until recently, most leading systems were only available through closed ...